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Abstract 
Efficient gene delivery is a fundamental goal of biotechnol-
ogy and has numerous applications in both basic and applied 
science. Substrate-mediated delivery and reverse transfec-
tion enhance gene transfer by increasing the concentration of 
DNA in the cellular microenvironment through immobilizing 
a plasmid to a cell culture substrate prior to cell seeding. In 
this report, we examine gene delivery of plasmids that were 
complexed with cationic polymers (polyplexes) or lipids (lipo-
plexes) and subsequently immobilized to cell culture or bio-
material substrates by adsorption. Polyplexes and lipoplexes 
were adsorbed to either tissue culture polystyrene or serum-
adsorbed tissue culture polystyrene. The quantity of DNA im-
mobilized increased with time of exposure, and the deposition 
rate and final amount deposited depended upon the proper-
ties of the substrate and complex. For polyplexes, serum mod-
ification enhanced reporter gene expression up to 1500-fold 
relative to unmodified substrates and yielded equivalent or 
greater expression compared to bolus delivery. For lipoplexes, 
serum modification significantly increased the number of 
transfected cells relative to unmodified substrates yet provided 
similar levels of expression. Immobilized complexes transfect 
primary cells with improved cellular viability relative to bolus 
delivery. Finally, this substrate-mediated delivery approach 
was extended to a widely used biomaterial, poly(lactide-co-
glycolide). Immobilization of DNA complexes to tissue culture 
polystyrene substrates can be a useful tool for enhancing gene 
delivery for in vitro studies. Additionally, adapting this sys-
tem to biomaterials may facilitate application to fields such as 
tissue engineering. 
Keywords: gene delivery, reverse transfection, solid-phase 
delivery, lipofectamine 2000, polyethylenimine, biomaterial, 
substrate-mediated
Introduction 
Controlled and efficient gene delivery and transgene ex-
pression is a fundamental goal of biotechnology, with nu-
merous applications in both basic and applied science. 
Nonviral vectors provide a versatile, simple to imple-
ment, and cost-effective approach for gene delivery and 
are continually being developed to increase transfection 
efficiency while reducing cellular toxicity. Traditionally, 
nonviral vectors are formed by complexation of plasmid 
DNA with cationic lipids (e.g., Lipofectamine) or cationic 
polymers (e.g., polyethylenimine, PEI), which reduces 
the negative surface charge, protects against degradation, 
and facilitates cellular internalization and intracellular 
trafficking of the plasmid. In vitro studies typically em-
ploy bolus addition of these complexes to the media, re-
sulting in internalization of approximately 20–50% of this 
plasmid (Tseng et al., 1997; Varga et al., 2001). Alternative 
delivery strategies have shown that increasing the con-
centration of DNA in the cellular microenvironment can 
increase transfection (Luo and Saltzman, 2000). 
Immobilizing DNA to the cell culture substrate prior 
to cell seeding has been proposed as a mechanism to in-
crease the concentration of DNA in the cellular microenvi-
ronment. Gene delivery from the culture surface, termed 
substrate-mediated delivery (Segura and Shea, 2002; Se-
gura et al., 2003), reverse transfection (Ziauddin and Saba-
tini, 2001), or solid-phase delivery (Bielinska et al., 2000), 
is being developed to enhance gene transfer and to create 
transfected cell arrays (Yoshikawa et al., 2004; Ziauddin 
and Sabatini, 2001). Several strategies have been developed 
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to associate DNA complexes with the substrate including 
specific binding of complexes to substrate through the bio-
tin–avidin interaction (Segura and Shea, 2002; Segura et al., 
2003), gelatin entrapment (Ziauddin and Sabatini, 2001), or 
nonspecific adsorption (Yoshikawa et al., 2004). These sys-
tems have shown the capacity to transfect cells cultured on 
the substrate, with deposition by adsorption transfecting 
the greatest number of cell types. The continued develop-
ment and application of this approach will benefit from an 
understanding of vector and substrate properties that me-
diate gene delivery. 
This report characterizes substrate binding and trans-
fection of DNA polyplexes and lipoplexes that are non-
specifically adsorbed to either tissue culture polystyrene 
(PS) or fetal bovine serum-coated polystyrene (FBS-PS). 
Maximal transfection from this approach requires that 
the affinity of the DNA complex for the substrate be suf-
ficient to support immobilization yet not so excessive as 
to limit cellular internalization. These studies have fo-
cused on manipulating the properties of the complex and 
substrate to modulate this binding affinity. Polyplexes 
and lipoplexes were examined based on their differences 
in chemical composition, size, and zeta potential, which 
may affect their interaction with the substrate. Addition-
ally, serum adsorption was used as a simple approach to 
modulate the interaction of these complexes with the cul-
ture substrate. Substrate binding and cellular transfection 
(i.e., transfected cells, transgene expression) were mea-
sured for polyplexes and lipoplexes formed with vary-
ing amounts of cationic polymer or lipid, respectively. 
The mechanism of gene transfer was examined through 
the distribution and stability of complexes on the sub-
strate. Furthermore, we demonstrate that substrate-medi-
ated delivery can transfect primary human-derived cells 
and that this approach can be extended to widely used 
biomaterials. 
Materials And Methods 
Materials 
Plasmid DNA encoding for luciferase or enhanced green 
fluorescent protein (EGFP) with a CMV promoter was 
purified from bacteria culture using Qiagen (Santa Clara, 
CA) reagents and stored in Tris-EDTA buffer (10 mM 
Tris, 1 mM EDTA, pH 7.4). Branched polyethylenimine 
(PEI, 25 kDa) was purchased from Aldrich (St. Louis, 
MO). Lipofectamine 2000 was purchased from Life Tech-
nologies (Gaithersburg, MD). All other reagents were ob-
tained from Fisher Scientific (Fairlawn, NJ) unless other-
wise noted. 
Complex Formation and Immobilization 
Addition of cationic polymers or lipids to plasmid DNA 
results in self-assembly to form colloidal polyplexes and 
lipoplexes, respectively. The complexing agents used 
were the branched cationic polymer polyethylenimine 
(PEI) and Lipofectamine 2000. Complexes with PEI, 
termed polyplexes, were formed at the desired N/P ratio 
(range 5–25), while DNA complexed with Lipofectamine 
2000, termed lipoplexes, were formed at several ratios of 
DNA/lipid (μg/μL, range 0.5–5). For polyplexes, poly-
mer solution (final volume of 40 μL in Tris-buffered sa-
line, TBS) was added dropwise to DNA (final volume 
of 60 μL in TBS), vortexed, and incubated for 15 min at 
room temperature. For lipoplexes, lipid (final volume 50 
μL in serum-free cell growth media, DMEM) was added 
dropwise to DNA (final volume 50 μL in serum-free cell 
growth media, DMEM), mixed by gentle pipetting, and 
incubated for 20 min. Lipoplexes were formed in serum-
free cell growth media. Zeta potential and z-average di-
ameter were measured with a Zetasizer Nano ZS (Mal-
vern, Worcestershire, United Kingdom).
Complexes were immobilized by incubation on either 
untreated or serum-coated tissue culture polystyrene. Tis-
sue culture polystyrene (PS, 96-well strip plate; Corning, 
Corning, NY) was serum-coated (FBS-PS) by incubation 
with heat-inactivated fetal bovine serum (FBS, 200 μL, 
10% in PBS, pH 7.4) for 2 h, followed by two wash steps 
with PBS. Complexes were immobilized immediately fol-
lowing complex formation by incubation of DNA com-
plexes (100 μL) with the substrate for 1–24 h and were 
then washed twice with TBS for polyplexes and serum 
free cell growth media for lipoplexes. 
Surface Characterization 
Tissue culture polystyrene (PS) was used as provided 
or after modification with fetal bovine serum (FBS-PS). 
Modification was characterized using X-ray photoelec-
tron spectroscopy (XPS), which excites a surface by X-
ray irradiation, allowing determination of the binding en-
ergy of ejected electrons. These binding energies can be 
correlated to the atomic species present on the surface as 
well as the chemical of the atoms. XPS spectra were re-
corded using an Omicron ESCAProbe system with an Al/
Mf anode X-ray source. The wettability of the surfaces 
was determined through measurement of the contact an-
gle of water droplets on the surface in air. Contact angles 
were determined at room temperature with a goniome-
ter (Ramé-Hart, Mountain Lakes, NJ), which is equipped 
with a camera system and DROPimage Standard soft-
ware. A water droplet was dispensed, and angle mea-
surements were recorded as the angle between the point 
of contact of the droplet with the solid surface and a tan-
gent with the droplet profile. 
Quantification of Immobilized DNA and DNA Release 
The binding and release of DNA from the substrates was 
monitored using plasmid DNA radio-labeled with a-32P 
dATP. Briefly, a nick translation kit (Amersham Pharma-
cia Biotech, Piscataway, NJ) was used following the man-
ufacturer’s protocol with minor modifications (Segura et 
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al., 2003). Following immobilization and washing, the sur-
face density of the complex was determined by immers-
ing individual wells in scintillation cocktail (5 mL, Scin-
tiVerse II) for measurement with a scintillation counter. 
The counts were correlated to DNA mass using a stan-
dard curve. To determine the release profile, substrates 
with immobilized DNA were incubated with PBS or con-
ditioned media (cell growth media that had been in cul-
ture with cells for at least 24 h; 200 μL) at 37°C in a humid 
chamber. At predetermined time points, half of the solu-
tion (100 μL) was removed and replaced with fresh solu-
tion. The activity of the collected sample was measured in 
a scintillation counter. At the final time point, the counts 
remaining on the substrate were also determined. The 
percentage of DNA released was calculated as the ratio of 
the cumulative counts released through a given time di-
vided by the total counts initially on the substrate. 
Cell Culture and Transfection 
Transfection studies were performed with NIH/3T3 
(ATCC, Manassas, VA) cells cultured at 37°C and 5% 
CO2
 in DMEM (Life Technologies) supplemented with 
1% sodium pyruvate, 1% penicillin–streptomycin, 1.5 g/
L NaHCO3, and 10% fetal bovine serum (FBS). Human 
dermal fibroblasts (HDF) were obtained per protocol of 
the IRB and Office for the Protection of Research Sub-
jects at Northwestern University and cultured as previ-
ously described (Mogford et al., 2002). Cells were seeded 
at a density of 5,000 cells per well in 96-well plates. For 
substrate-mediated delivery, cells were seeded immedi-
ately following complex immobilization and wash. Con-
trol studies were performed with bolus delivery to cells 
plated in a 48-well dish at a density of 15,000 cells/well 
and cultured overnight before complexes were added. 
The quantity of DNA delivered as a bolus was equivalent 
to the amount of DNA immobilized to the substrate, with 
normalization to the larger well. Complexes were formed 
as described above, but with a final volume of 30 μL and 
polyplexes and 75 μL for lipoplexes. Transfection was an-
alyzed following a 48-h culture. 
Transfection was characterized through the extent of 
transgene expression (luciferase levels) and the number 
of transfected cells (GFP expression). The extent of trans-
Figure 1. Diameter and zeta-potential of DNA complexes. (A) z-Average diameter and (B) zeta potential of PEI polyplexes with 
increasing polymer/ DNA ratio (N/P). (C) z-Average diameter and (D) zeta potential of Lipofectamine 2000 lipoplexes with in-
creasing volumes of lipid used to complex 1 μg of DNA. Data are presented as average ± standard deviation of the mean. *P < 0.05 
relative to remaining data (A); **P < 0.05 relative to N/P equal to 5 (B); ***P < 0.05 relative to 0.5 μL of lipid. For this and all other 
figures, P values were obtained using Student’s t-test with single comparisons. 
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gene expression was quantified by measuring the lucif-
erase activity using the Luciferase Assay System (Pro-
mega, Madison, WI). Cells were lysed and assayed for 
enzymatic activity after 48 h. The luminometer was set 
for a 3-s delay with signal integration for 10 s. Luciferase 
activity was normalized to the number of cells seeded. 
Transfected cells were visualized and manually counted 
using an epifluorescence microscope (Leica, Bannock-
burn, IL) with a FITC filter and equipped with a digi-
tal camera. The percentage of transfected cells was cal-
culated as the ratio of the number of transfected cells 
divided by total cell number, which was determined by 
manual counting of phase images. Viability of the cell 
population was analyzed using the (3-(4,5-dimethylthi-
azol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-
nyl)-2H-tetrazolium, inner salt (MTS) assay (Promega, 
Madison, WI), which reports on the metabolic activity 
(Barltrop et al., 1991). The manufacturer’s protocol was 
followed. Briefly, MTS reagent was added (20% of cul-
ture volume) to the cultures, and after a 1.5-h incubation, 
the absorbance at 490 nm was measured with a spectro-
photometer. The relative cell viability is reported as the 
absorbance for the experimental condition divided by 
the absorbance for cells grown on PS substrates (no se-
rum, DNA, or transfection reagent). 
Confocal Microscopy 
DNA complexes were fluorescently labeled with tetra-
methyl rhodamine (Mirus, Madison, WI). Polyplexes 
were then immobilized followed by cell seeding as de-
scribed above. Cells were cultured for 20 h and then la-
beled with the cytoplasmic stain fluorescein diacetate 
(Sigma, St. Louis, MO). The distribution of cells and com-
plexes on the substrate was visualized with confocal mi-
croscopy (Leica). 
PLG Disk 
The biomaterial poly(lactide-co-glycolide) (PLG) was 
fabricated into a disk using a gas foaming process (Jang 
and Shea, 2003; Nof and Shea, 2002). After fabrication, 
disks were coated with serum, and complexes were incu-
bated with the disk for 24 h as described above. After be-
ing washed, cells were seeded onto the disk. Transgene 
expression was determined using the luciferase assay as 
previously described. Transfected cells were visualized 
by delivering a plasmid encoding for nuclear targeted β-
galactosidase and staining with X-gal following culture 
(Shea et al., 1999). 
Results 
Complex Formation and Surface Modification 
The z-average diameter and zeta potential of DNA com-
plexes, which may impact substrate immobilization and 
transfection, were measured (Figure 1) and are consis-
tent with published reports (Ogris et al., 1999; Son et al., 
2000; Zhang et al., 2001). The z-average diameter (dz) of 
the polyplexes decreased with increasing amounts of cat-
ionic polymer in the complex, with mean diameters rang-
ing from 1062 ± 140 nm to 121 ± 10 nm (P < 0.05) for N/P 
ratios of 5 and 25, respectively (Figure 1A). Increasing the 
amount of cationic polymer led to increases in the zeta 
potential of polyplexes, which ranged from –14.33 mV to 
a maximum of 21.21 mV at an N/P of 10 (Figure 1B). N/P 
ratios greater than 10 did not significantly affect the zeta 
potential (P > 0.05). Lipoplexes had a mean dz that ranged 
from 603 ± 104 nm to 1089 ± 340 nm (P < 0.05) for increas-
ing amounts of lipid (Figure 1C). For DNA/lipid ratios 
greater than 1:2, increasing the amount of lipid had no 
significant effect on the zeta potential (P > 0.05) and aver-
aged –50 mV (Figure 1D). 
The altered surface chemistry induced by serum coat-
ing was confirmed with X-ray photon spectroscopy (XPS) 
and contact angle measurements. The XPS spectrum indi-
cates that nitrogen groups are present on FBS-PS but not 
on PS (Figure 2). Serum coating also increased the wetta-
bility of the surfaces as determined by contact angle mea-
surements (Table I). The FBS treated surfaces had a low 
contact angle (<15°) relative to the PS surface (48°). 
Complex Immobilization and Stability 
The amount of DNA immobilized to the surfaces in-
creased with time of incubation on the surface and was 
dependent upon the chemical properties of the sur-
face and DNA complex (Figure 3A). Incubation of DNA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. X-ray photoelectron spectrum of polystyrene and se-
rum-modified polystyrene surfaces; peak denoted by the ar-
row indicates the presence of nitrogen on the substrate. 
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complexes with the substrate for 24 h resulted in surface 
densities of at least 4 μg/cm2, which corresponds to im-
mobilization of more than 60% of the DNA. Polyplex de-
position on PS and FBS-PS occurred at similar rates dur-
ing the first 8 h of incubation; however, deposition onto 
FBS-PS slowed relative to PS during the final 16 h, result-
ing in surface densities of 4.1 and 5.3 μg/cm2 (P < 0.05), 
respectively. Lipoplex binding to the substrate was not 
substantially affected by the surface properties during the 
24-h incubation (P > 0.05). 
The retention of polyplexes, but not lipoplexes, on both 
PS and FBS-PS substrates during incubation in PBS was 
unaffected by surface modification. For polyplexes, incu-
bation in PBS resulted in 9% and 8% (P < 0.05) release af-
ter 8 days from PS and FBS-PS, respectively (Figure 3B). 
For lipoplexes, incubation in PBS resulted in 6% and 12% 
(P < 0.05) release after 8 days from PS and FBS-PS, respec-
tively (Figure 3B). The release of polyplexes gradually in-
creased during the 8-day incubation in PBS, whereas lipo-
plexes reach maximal release after 2–4 days. Transfection 
experiments typically involve cell culture for 24–96 h, 
which corresponds to release of 2.75–10% of immobilized 
DNA. 
Increasing the quantity of DNA incubated with the 
substrate resulted in increased quantities of immobilized 
DNA; however, the percentage of DNA immobilized after 
Table I. Contact angle measurements for substrates (water). 
Surface  Contact angle (deg) 
Tissue culture polystyrene (PS)  47.75 ± 6.64 
FBS modified tissue culture polystyrene (FBS-PS)  12.67 ± 3.13 
Figure 3. DNA deposition and stability. (A) Polyplexes (circles) and lipoplexes (triangles) were deposited onto polystyrene (●, 
▲) and serum-coated polystyrene (○, ∆) for 24 h. Substrates were incubated with 2 μg of DNA; (B) immobilized polyplexes and 
lipoplexes were exposed to phosphate-buffered saline (PBS, pH 7.4); (C) conditioned media; (D) polyplexes incubated with cell 
growth media (●, PS; ○, FBS-PS), and trypsin (■, PS; □, FBS-PS) at 37°C. Data are presented as average ± standard deviation of the 
mean. *P < 0.05 relative to FBS-PS deposition of polyplexes after 24 h; **P × 0.05 relative to lipoplexes released from PS at 8 days.  
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a 2-h incubation is dependent upon surface modification 
and complex properties (Figure 4). For polyplexes immo-
bilized to PS substrates, increasing the quantity of DNA in-
cubated on the surface led to a greater percentage immobi-
lized for all N/P ratios (P < 0.05) (Figure 4A). Furthermore, 
increasing the N/P ratio resulted in decreasing quantities 
of immobilized DNA. Conversely, polyplexes immobilized 
to FBS-PS substrates exhibited no dependence on DNA 
quantities or N/P ratio (P > 0.05). Lipoplex binding to PS 
substrates exhibited a dependence on DNA concentration, 
with lower concentrations binding more effectively than 
higher concentrations. This trend was significant for FBS-
PS at the lower lipid content (P < 0.05). The lipid content of 
the complexes did not affect the percentage bound to the 
substrate on both PS and FBS-PS substrates. 
Cellular Transfection 
The extent of transgene expression on substrates with 
immobilized polyplexes and lipoplexes depended upon 
substrate modification and complex formulation (Fig-
ure 5). Polyplexes and lipoplexes immobilized to FBS-PS 
substrates yielded equal or greater transgene expression 
than delivery from PS. For immobilization of small quan-
tities of DNA (0.5 μg), FBS-PS substrates yielded 17-fold 
greater transgene expression than PS (P < 0.05) at an N/P 
of 25, and similar levels for an N/P of 10 (Figure 5A). For 
immobilization of large quantities of DNA (2 μg), trans-
gene expression on FBS-PS was increased 194- and 1638-
fold compared to PS (P < 0.05) surfaces for N/P equal 
to 10 and 25, respectively (Figure 5B). Polyplex delivery 
from FBS-PS surfaces enhanced expression 20- to 49-fold 
relative to equivalent doses delivered in bolus (P < 0.05), 
with the exception that the largest dose and N/P ratio 
provided similar expression levels. 
Lipoplex delivery from PS and FBS-PS yielded equal 
levels of luciferase activity under similar dosage and com-
plex conditions. At low-dose conditions, increasing the 
lipid content of the complexes led to a 6.5-fold enhance-
ment in luciferase activity (Figure 5C), which was not ob-
served at the larger dose (Figure 5D). For lipoplexes with 
the lowest lipid content and at the highest dose, an 18-
fold enhancement in activity was observed from serum-
modified surfaces when compared to bolus delivery. 
Otherwise, transgene expression was similar between 
substrate-mediated and bolus delivery. 
The similar levels of transgene expression obtained 
by lipoplex delivery from both PS and FBS-PS substrates 
were further examined by quantifying the percentage of 
transfected cells (Figure 6). The percentage of transfected 
cells increased nearly 2-fold on FBS-PS relative to PS, in-
dependent of quantity immobilized and lipoplex formu-
lation (Figure 6A,B; P < 0.05). Substrate-mediated deliv-
ery from FBS-PS resulted in similar or greater percentages 
of transfected cells relative to bolus delivery. Polyplexes 
delivered from FBS-PS surfaces also had greater percent-
ages of cells transfected compared to PS surfaces; how-
ever, transfection efficiencies were low (<10%, data not 
shown). 
The viability of NIH/3T3 cells was similar for transfec-
tion by both bolus and substrate-mediated delivery, with 
the viability affected by the transfection reagent but not 
the substrate preparation. Substrate mediated delivery 
showed similar trends to bolus delivery on the different 
substrates (PS and FBS-PS). Modification of the polysty-
rene substrate with serum does not influence cell viabil-
ity as cells yield similar metabolic activities on both sub-
strates (Figure 7). Polyplex delivery from the substrate or 
as a bolus did not affect viability (P > 0.05). Delivery of li-
poplexes reduced viability relative to polyplex delivery; 
Figure 4. DNA adsorption to surface. Polyplexes and lipoplexes were incubated on (A) PS and (B) FBS-PS surfaces for 2 h. Black 
bars indicate 2 μg, and gray bars indicate 0.5 μg of DNA incubated on the surface. Data are presented as average ± standard de-
viation of the mean. High doses have P < 0.05 relative to corresponding low doses at the same N/P (A). *P < 0.05 relative to other 
polyplex conditions.  
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however, similar levels of viability were observed for bo-
lus and substrate delivery. 
Cell–Complex Interaction 
The ability of cells to promote release of complexes from 
the substrate for subsequent internalization was exam-
ined by performing release studies with conditioned 
growth media (Figure 3). In conditioned media, the re-
lease of DNA complexes was greater from FBS-PS com-
pared to PS substrates (Figure 3C). After 8 days, 35% of 
polyplexes were released from PS substrates and 47% 
were released from FBS-PS substrates (P < 0.05) in con-
ditioned media. These numbers are significantly greater 
than the release in PBS (P < 0.05) (Figure 3B). Lipoplexes 
exhibited similar dependence on serum coating, with 23% 
and 15% released from FBS-PS and PS substrates, respec-
tively. Immobilized polyplexes were also incubated with 
either serum-containing media (not conditioned) or tryp-
sin in order to identify which components of conditioned 
media mediate release (Figure 3D). After 8 days, 18% and 
36% of complexes released from PS and FBS-PS substrates 
in serum-containing media, and 5% released in trypsin 
from both substrates. 
The differences in transfection observed between PS 
and FBS-PS were subsequently examined using confo-
Figure 5. Transgene expression by substrate-mediated delivery. (A,B) Polyplexes and (C,D) lipoplexes with plasmid encoding for 
luciferase were incubated on substrates at low (0.5 μg; A, C) and high (2.0 μg; B, D) doses for 2 h. Bolus delivery used equivalent 
amounts of DNA that were immobilized to the substrate: (A) 0.2 μg/cm2, (B) 0.5 μg/cm2, (C) 0.25 μg/cm2, and (D) 0.1 μg/cm2. 
Activity was normalized to the number of cells seeded. Data are presented as average ± standard deviation of the mean. *P < 0.05 
relative to other delivery methods for that condition; **P < 0.05 at different complex conditions.  
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cal microscopy to determine the relative distribution of 
polyplexes and cells on the substrate. Conditions with 
relatively low (PS) and high (FBS-PS) rates of transfec-
tion were compared to identify differences in the com-
plex distribution (N/P 25, 2 μg incubated on the surface). 
Polyplexes immobilized to PS, which had a low transfec-
tion rate, were distributed across the surface, and only 
a fraction of the complexes were associated with cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Figure 8A). Seeding cells seeded onto DNA adsorbed 
FBS-PS substrates that yielded higher transfection led to 
polyplexes that were not distributed across the substrate 
but localized to the cells or in their vicinity. Thus, poly-
plexes had a higher cellular association when delivered 
from serum-modified surfaces compared to unmodified 
surfaces. 
Primary Cell Transfection 
The ability of substrate-mediated delivery to transfect 
primary cells was assessed using human dermal fibro-
blasts (HDF), a primary cell type that has been difficult 
to transfect due to cytotoxicity (Uchida et al., 2002). Li-
poplexes delivered as a bolus resulted in large amounts 
of cellular debris, poor cell morphology, and reduced 
cellular viability (Figure 9A). For substrate-mediated de-
livery, the fibroblasts had a morphology similar to that 
observed during typical cell culture (Figure 9B). Trans-
gene expression was greatest for HDFs cultured on FBS-
PS, for both immobilized polyplexes and lipoplexes 
(Figure 9C,D). Polyplexes delivered from an FBS-PS sur-
face yielded 10.7-fold greater luciferase expression when 
compared to PS (P < 0.05), with bolus delivery produc-
ing luciferase activity similar to FBS-PS. Lower doses of 
complexes delivered as a bolus resulted in insignificant 
luciferase activity (data not shown). Consistent with the 
NIH/3T3 culture, lipoplex delivery by substrate immo-
bilization resulted in similar expression levels indepen-
dent of substrate modification (FBS-PS, PS) and the lipid 
content. Additionally, transgene expression for poly-
plexes and lipoplexes were similar; however, the per-
centage of transfected cells using lipoplexes was approx-
Figure 6. Transfected cell numbers by substrate-mediated delivery. Lipoplexes with plasmid encoding for GFP were incubated on 
substrates with quantities of (A) 0.5 μg and (B) 2 μg for 2 h. Bolus delivery used equivalent amounts of DNA that were immobi-
lized to the substrate: (A) 0.25 μg/cm2 and (B) 0.1 μg/cm2. Data are presented as average ± standard deviation of the mean. *P < 
0.05 relative to the other delivery methods for that condition. 
Figure 7. Cellular viability. The MTS assay was used to deter-
mine cellular viability on serum-modified substrate. The MTS 
assay was also used to determine cellular viability after delivery 
of complexes from FBS-PS and PS substrates and through bolus 
delivery. Data are presented as average ± standard deviation of 
the mean. *P < 0.05 relative to cellular viability on PS (control).  
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imately 26%, whereas polyplex immobilization resulted 
in less than 5% of the cells transfected. 
Transfection From a Biomaterial Scaffold 
The extension of substrate-mediated delivery by complex 
adsorption to biomaterial scaffolds was subsequently ex-
amined, which could facilitate the application of this ap-
proach to in vivo gene transfer. Poly(lactide-co-glycolide) 
(PLG) disks were incubated with polyplexes, resulting 
in the immobilization of 1.3 μg onto a 5-mm disk. Trans-
fected NIH/3T3 cells were visible across the substrate 
(Figure 10), and transgene expression was measured at 1.3 
× 105 RLU/ 5000 cells seeded. These results demonstrate 
Figure 8. Distribution of cells and polyplexes on substrate following cell culture. Confocal microscopic images of polyplexes on 
(A) PS and (B) FBS-PS 20 h after cell seeding. Polyplexes (2 μg, N/P = 25) were incubated on substrates for 2 h followed by wash-
ing and cell seeding. Images were captured 20 h after cell seeding. Plasmid was labeled with tetramethylrhodamine, and cells 
were stained with fluorescein diacetate. 
Figure 9. Transfection of primary human dermal fibroblasts. (A) GFP expression from bolus delivery of 0.5 μg lipoplexes. (B) GFP 
expression from FBS-PS substrate-mediated delivery of 1 μg lipoplexes incubated on substrate. Luciferase activity from substrate 
and bolus delivery of (C) polyplexes and (D) lipoplexes. Data are presented as average ± standard deviation of the mean. *P < 0.05 
relative to other delivery methods for that condition.  
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the potential to apply substrate-mediated delivery to al-
ternative substrates other than PS. 
Discussion 
This report characterizes gene transfer by DNA com-
plexes adsorbed to tissue culture polystyrene and extends 
this approach to a biomaterial substrate. Polyplexes and 
lipoplexes were adsorbed to either unmodified (PS) or se-
rum-adsorbed (FBS-PS) polystyrene. Complex immobili-
zation to the substrate increased with time of exposure, 
while deposition depended upon the properties of the 
substrate and complex. Polyplexes immobilized to FBS-
PS provided greater transfection than polyplexes immo-
bilized to PS and equivalent or greater transfection than 
bolus delivery. Lipoplexes, however, provided similar 
levels of transgene expression on serum-coated and un-
coated substrates. Interestingly, transfection on serum-
coated surfaces increased the number of transfected cells 
relative to unmodified substrates. Immobilized com-
plexes are able to transfect primary cells and resulted in 
improved cellular viability relative to bolus delivery. Fi-
nally, this delivery mechanism was adapted to a biomate-
rial substrate, PLG, which is commonly used in biomedi-
cal applications such as tissue engineering. 
Reverse transfection and substrate-mediated delivery 
are based on the immobilization of DNA complexes to the 
culture substrate. Substrate-mediated delivery mimics the 
intrinsic binding of viruses to extracellular matrix. For ex-
ample, retroviral vectors bind to fibronectin (Hanenberg 
et al., 1996; Lei et al., 2002) to facilitate internalization. Vi-
ral vectors have also been designed that specifically inter-
act with natural and synthetic biomaterials through the 
use of antibodies or covalent coupling (Abrahams et al., 
2002; Klugherz et al., 2002; Stachelek et al., 2004). Reverse 
transfection was performed by suspending plasmid in 
gelatin and spotting onto a slide and is followed by lipid 
addition to the culture media (Ziauddin and Sabatini, 
2001). Substantial transfection of HEK 293 cells was ob-
served using this approach, and may require some modi-
fication to transfect other cell types (Bailey et al., 2002; Wu 
et al., 2002). An alternative to the DNA/gelatin immobi-
lization procedure involves the complexation of plasmid 
with cationic lipids or polymers and then immobilization 
of these complexes to the substrate. Biotin residues have 
been attached to cationic polymers, and mixed with plas-
mid to facilitate specific binding of DNA complexes to 
an avidin-modified substrate (Segura and Shea, 2002; Se-
gura et al., 2003). Increasing the number of biotin residues 
enhanced substrate binding, whereas maximal transfec-
tion of HEK293T and NIH/3T3 cells was observed with 
few numbers of biotin residues. Alternatively, complexes 
can be nonspecifically adsorbed to the substrate, likely 
through interactions between the cationic lipid or poly-
mer and the substrate. Complexes have been formed in 
the presence of extracellular matrix components and dried 
onto the substrate (Yoshikawa et al., 2004). This approach 
transfected a variety of cell types, including human mes-
enchymal stem cells. We report on polyplex and lipoplex 
binding to the substrate from solution and the ability to 
transfect cell lines and primary human-derived cells. In-
terestingly, primary cells demonstrated an increased cel-
lular viability, which may result from washing of the sub-
strates to remove unbound lipid or polymer that can be 
cytotoxic (Godbey et al., 1999). Our studies characterize 
properties of the substrate and the complexes that medi-
ate substrate immobilization and transgene expression, 
which serve to elucidate substrate and vector properties 
that optimize gene transfer. 
Incubation of lipoplexes or polyplexes with the tis-
sue culture substrates results in nonspecific adsorption 
of the complexes. The adsorption of polyplexes was ex-
pected based on the use of PEI as a coating material for 
culture substrates. Although the mechanisms of DNA 
complex adsorption to substrates have not been well-
studied, the mechanisms of protein adsorption may pro-
vide insight regarding these interactions. Nonspecific ad-
sorption occurs through electrostatic interactions, van der 
Waals forces, and hydrophobic interactions. In this re-
port, an increasing polyplex charge did not increase poly-
plex adsorption suggesting that electrostatic interactions 
are not the only mechanism of binding. Interactions be-
tween proteins and substrates have been characterized 
by (i) changes in the hydration of the surface and protein 
molecule, (ii) charge interactions between the protein and 
the surface, and (iii) structural rearrangement of the ad-
sorbing molecule (Norde and Lyklema, 1991). The affin-
ity for the substrate depends upon the substrate–biomole-
cule interactions, conformational changes that occur upon 
binding and the solution properties from which the mol-
ecule is adsorbing. Adsorption to hydrophobic substrates 
is regulated by entropy (Norde, 1986), and the conforma-
tion changes induced upon binding may contribute to ir-
reversible binding (Stuart et al., 1991). Hydrophilic sub-
strates generally result in reversible interactions, and the 
driving force for adsorption is typically enthalpic. The 
different responses observed on PS and on FBS-PS may 
reflect changes in the hydrophobicity of the substrate or 
variations in the molecular interactions between the com-
Figure 10. Substrate-mediated transfection of NIH/3T3 fibro-
blasts from serum-coated PLG substrates. Polyplexes (5 μg) con-
taining plasmid encoding for β-galactosidase were incubated for 
24 h. Transfected cells appear blue, as indicated with the arrow.  
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plex and substrate. Similarly, complexes were expected to 
adsorb to serum-modified substrates due to their known 
interaction with serum components (Moret et al., 2001; 
Zelphati et al., 1998). We propose that the molecular-scale 
design of the DNA complex and the substrate can be em-
ployed to regulate the molecular interactions (e.g., elec-
trostatic, van der Waals, hydrophobic) and will lead to 
optimal transfection by a substrate-mediated approach. 
Maximal transfection from the substrate is hypothe-
sized to represent a balance between complex binding 
to the substrate and cellular internalization. Transfection 
was observed with both polyplexes and lipoplexes ad-
sorbed to serum modified and unmodified polystyrene, 
suggesting that substrate-mediated delivery is applicable 
to a variety of transfection reagents and substrates. Serum 
coating of polystyrene can enhance transgene expression 
(polyplexes) or the percentage of transfected cells (lipo-
plexes). Serum coating of PS was hypothesized to influ-
ence either complex adsorption and release or enhance the 
cellular viability. For NIH/3T3 cells, serum-modified sub-
strates did not enhance their viability relative to PS (Fig-
ure 7), suggesting that the serum may affect adsorption 
or release. Addition of serum containing media (pre- and 
post-conditioning) to the immobilized complexes signifi-
cantly enhanced release of the complexes relative to incu-
bation with PBS, whereas incubation with trypsin yielded 
release levels less than PBS (Figure 3). These observations 
suggest that complex release from the substrate mediated 
by competitive binding of serum that displaces the com-
plexes. The internalization of released and substrate-asso-
ciated complexes, and DNA distribution among the cell 
populations are the focus of continuing studies. 
Substrate-mediated delivery yields comparable lev-
els of transgene expression to bolus delivery but pro-
vides a mode of transfection useful in the development 
of research tools, such as transfected cell arrays, and that 
may be translated to in vivo gene transfer from biomate-
rials. Substrate immobilization distributes the DNA com-
plexes across the substrate, which may enhance the cel-
lular distribution and increase the number of transfected 
cells. Immobilization to the substrate also limits complex 
aggregation (Segura et al., 2003), and smaller particles 
may traffic differently than larger complexes (Ogris et 
al., 2001). Transgene expression levels and the number of 
cells expressing the transgene may be improved by sub-
strate mediated delivery and this report identifies some 
of the design considerations. Cellular transfection by the 
immobilized DNA complexes was not equivalent across 
substrates and transfection reagents. Measurements of 
transgene expression characterize the total protein pro-
duction, whereas the transfected cell number reflects the 
efficacy of delivery throughout the cell population. These 
differences in the transfection profile do not reflect sub-
stantial differences in the amount of DNA immobilized 
(Figure 4) and may result from differences in cellular in-
ternalization from the substrate and intracellular traf-
ficking resulting from the different vectors. Conditions 
with relatively low transfection (PS) had DNA localized 
to the substrate, whereas conditions with higher transfec-
tion (FBS-PS) showed less substrate-associated DNA and 
more cell-associated DNA (Figure 8). 
Maximal transgene expression for polyplexes and li-
poplexes by substrate-mediated delivery is similar, yet 
the transfection profile and dependence on the substrate 
properties reflect differences in composition and intrin-
sic transfection properties. Polyplex delivery from serum-
modified substrates can increase transgene expression 
relative to delivery from PS and to equivalent quantities 
delivered as a bolus. Serum modification enhanced trans-
gene expression up to 1600-fold relative to unmodified 
PS, indicating that substrate properties dramatically af-
fect delivery. Lipoplex delivery, however, yielded simi-
lar levels of expression across delivery methods, yet se-
rum modification was able to significantly increase the 
percentage of transfected cells. Increasing the amount of 
immobilized lipoplexes depressed the expression levels, 
which is similar to observations with bolus lipoplex de-
livery. Cellular exposure to excessive quantities of lipo-
plexes can adversely affect proliferation and viability, 
thereby reducing transgene expression. These differences 
in transfection between polyplexes and lipoplexes likely 
result from variations in the complexation agent chemis-
try (e.g., lipid, polymer) and the physical properties (e.g., 
size, zeta potential) of the DNA complex, which would 
affect molecular interactions between the complex and 
substrate. Polyplexes and lipoplexes have substantially 
different z-average diameters, zeta-potential, and chemi-
cal composition (Figure 1). Increasing the N/P ratio for 
polyplexes increases their zeta potential and reduces their 
size (Boussif et al., 1995; Choosakoonkriang et al., 2003; 
Ogris et al., 1999). Conversely, altering the composition of 
lipoplexes has less marked effects on the complex diame-
ter and zeta-potential. Transfection of primary cells or cell 
lines can have significant variations due to numerous cell 
and vector properties, such as proliferation, metabolism, 
internalization, and intracellular trafficking. Transfec-
tion of primary cells can involve further obstacles, such 
as the differential expression of cell surface proteoglycans 
or decreased viability caused by the transfection reagent 
(Uchida et al., 2002). Substrate-mediated delivery may de-
crease the amount of DNA, or the quantity of transfection 
reagent, which may enhance either transfection or viabil-
ity for primary cells. 
Immobilization of DNA complexes by adsorption can 
be extended to biomaterials for applications such as tis-
sue engineering. Expression levels achieved were compa-
rable to transfection on polystyrene and suggest that sub-
strate-mediated delivery is a generalizable phenomenon; 
the optimal design of biomaterial substrates may also fa-
cilitate the translation of this approach to in vivo appli-
cations. Porous PLG or collagen scaffolds have been fab-
ricated with encapsulated polyplexes or lipoplexes and 
have achieved substantial transfection in vitro (Cohen-
Sacks et al., 2004; Huang et al., 2003; Scherer et al., 2002) 
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and in vivo (Scherer et al., 2002). The presence of the cat-
ionic lipid or polymer can significantly alter the release 
profile compared to plasmid DNA (Huang et al., 2003; 
Shea et al., 1999). The biotin–avidin interaction has been 
used to bind both viral and nonviral vectors to a variety 
of materials (Levy et al., 2001; Segura et al., in press). Al-
ternatively, complexes formed with polyamidoamine 
(PAMAM) dendrimers have been dried onto PLG and 
collagen membranes coated with phosphatidyl glycerol 
(1–5%) (Bielinska et al., 2000). In vitro transfection was 
comparable to bolus controls, while in vivo delivery en-
hanced expression 6- to 8-fold relative to plasmid deliv-
ery. Alternatively, plasmid DNA has also been incorpo-
rated into inorganic calcium phosphate co-precipitates 
that are adsorbed onto PLG matrices, and are mostly re-
leased by 48 h (Kofron and Laurencin, 2004). This report 
demonstrates the ability to adsorb complexes to PLG to 
obtain significant transfection on the substrate and sug-
gests that this strategy may be useful for tissue-engineer-
ing applications. 
Acknowledgments
Support for this research was provided in part by grants from 
National Institutes of Health (contract grant numbers  RO1 
GM066830 [L.D.S.] and RO1 GM 41303 [T.A.M.], the Special-
ized Program of Research Excellence (SPORE) in Breast Can-
cer of the National Cancer Institute, and the Christopher 
Reeve Paralysis Foundation, and National Science Foundation. 
A.K.P. is supported by a NSF Graduate Research Fellowship. 
XPS measurements were performed at Keck-II/NUANCE, and 
confocal images were obtained in the Biological Imaging Facil-
ity at Northwestern University (Evanston, IL). We thank Kin-
jal Shah and Biliana Marcheva (Northwestern University) for 
technical assistance. 
References 
Abrahams JM, Song C, DeFelice S, Grady MS, Diamond SL, 
Levy RJ. 2002. Endovascular microcoil gene delivery using 
immobilized antiadenovirus antibody for vector tethering. 
Stroke 33(5):1376–1382. 
Bailey SN, Wu RZ, Sabatini DM. 2002. Applications of trans-
fected cell microarrays in high-throughput drug discovery. 
Drug Discovery Today 7(18 Suppl):S113–118. 
Barltrop JA, Owen TC, Cory AH, Cory JG. 1991. 5-(3-Car-
boxymethoxyphenyl)- 2-(4,5-dimethylthiazolyl)-3-(4-
sulfophenyl)tetrazolium, inner salt (MTS) and related an-
alogs of 3-(4,5-dimethylthiazolyl)-2, 5-diphenyltetrazolium 
bromide (MTT) reducing to purple water-soluble forma-
zans as cell-viability indicators. Bioorg Med Chem Lett 
1(11):611–614. 
Bielinska AU, Yen A, Wu HL, Zahos KM, Sun R, Weiner ND, 
Baker JR Jr., Roessler BJ. 2000. Application of membrane-
based dendrimer/ DNA complexes for solid phase trans-
fection in vitro and in vivo. Biomaterials 21(9):877–887. 
Boussif O, Lezoualc’h F, Zanta MA, Mergny MD, Scherman D, 
Demeneix B, Behr JP. 1995. A versatile vector for gene and oli-
gonucleotide transfer into cells in culture and in vivo: Poly-
ethylenimine. Proc Natl Acad Sci USA 92(16):7297–7301. 
Choosakoonkriang S, Lobo BA, Koe GS, Koe JG, Middaugh 
CR. 2003. Biophysical characterization of PEI/DNA com-
plexes. J Pharm Sci 92(8):1710–1722. 
Cohen-Sacks H, Elazar V, Gao J, Golomb A, Adwan H, Ko-
rchov N, Levy RJ, Berger MR, Golomb G. 2004. Delivery 
and expression of pDNA embedded in collagen matrices. J 
Control Release 95(2):309–320. 
Godbey WT, Wu KK, Hirasaki GJ, Mikos AG. 1999. Improved 
packing of poly(ethylenimine)/DNA complexes increases 
transfection efficiency. Gene Ther 6(8):1380–1388. 
Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams 
DA. 1996. Colocalization of retrovirus and target cells on 
specific fibronectin fragments increases genetic transduc-
tion of mammalian cells. Nat Med 2(8):876–882. 
Huang YC, Connell M, Park Y, Mooney DJ, Rice KG. 2003. 
Fabrication and in vitro testing of polymeric deliv-
ery system for condensed DNA. J Biomed Mater Res 
67A(4):1384–1392. 
Jang JH, Shea LD. 2003. Controllable delivery of non-viral DNA 
from porous scaffolds. J Control Release 86(1):157–168. 
Klugherz BD, Song C, DeFelice S, Cui X, Lu Z, Connolly J, Hin-
son JT, Wilensky RL, Levy RJ. 2002. Gene delivery to pig 
coronary arteries from stents carrying antibody-tethered 
adenovirus. Hum Gene Ther 13(3):443–454. 
Kofron MD, Laurencin CT. 2004. Development of a calcium 
phosphate co-precipitate/poly(lactide-co-glycolide) DNA 
delivery system: Release kinetics and cellular transfection 
studies. Biomaterials 25(13): 2637–2643. 
Lei P, Bajaj B, Andreadis ST. 2002. Retrovirus-associated hep-
aran sulfate mediates immobilization and gene transfer on 
recombinant fibronectin. J Virol 76(17):8722–8728. 
Levy RJ, Song C, Tallapragada S, DeFelice S, Hinson JT, Vy-
avahare N, Connolly J, Ryan K, Li Q. 2001. Localized ad-
enovirus gene delivery using antiviral IgG complexation. 
Gene Ther 8(9):659–667. 
Luo D, Saltzman WM. 2000. Enhancement of transfection by 
physical concentration of DNA at the cell surface. Nat Bio-
technol 18(8): 893–895. 
Mogford JE, Tawil N, Chen A, Gies D, Xia Y, Mustoe TA. 2002. 
Effect of age and hypoxia on TGFbeta1 receptor expression 
and signal transduction in human dermal fibroblasts: im-
pact on cell migration. J Cell Physiol 190(2):259–265. 
Moret I, Esteban Peris J, Guillem VM, Benet M, Revert F, Dasi 
F, Crespo A, Alino SF. 2001. Stability of PEI–DNA and 
DOTAP–DNA complexes: effect of alkaline pH, heparin 
and serum. J Control Release 76(1–2):169–181. 
Nof M, Shea LD. 2002. Drug-releasing scaffolds fabricated 
from drug-loaded microspheres. J Biomed Mater Res 
59(2):349–356. 
Norde W. 1986. Adsorption of proteins from solution at 
the solid–liquid interface. Adv Colloid Interface Sci 
25(4):267–340. 
Norde W, Lyklema J. 1991. Why proteins prefer interfaces. J 
Biomater Sci Polym Ed 2(3):183–202. 
302 be nG al i e T al. i n Bi o tec h no l o g y a nd Bi o eng i ne e r i ng  90 (2005) 
Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. 1999. 
PEGylated DNA/transferrin–PEI complexes: reduced in-
teraction with blood components, extended circulation in 
blood and potential for systemic gene delivery. Gene Ther 
6(4):595–605. 
Ogris M, Steinlein P, Carotta S, Brunner S, Wagner E. 2001. 
DNA/ polyethylenimine transfection particles: influence 
of ligands, polymer size, and PEGylation on internaliza-
tion and gene expression. AAPS PharmSci 3(3):E21. 
Scherer F, Schillinger U, Putz U, Stemberger A, Plank C. 
2002. Nonviral vector-loaded collagen sponges for sus-
tained gene delivery in vitro and in vivo. J Gene Med 
4(6):634–643. 
Segura T, Chung PH, Shea LD. In Press. DNA delivery from 
hyaluronic acid-collagen hydrogels via a substrate-medi-
ated approach. Biomaterials. 
Segura T, Shea LD. 2002. Surface-tethered DNA complexes for 
enhanced gene delivery. Bioconjugate Chem 13(3):621–629. 
Segura T, Volk MJ, Shea LD. 2003. Substrate-mediated DNA 
delivery: role of the cationic polymer structure and extent 
of modification. J Control Release 93(1):69–84. 
Shea LD, Smiley E, Bonadio J, Mooney DJ. 1999. DNA delivery 
from polymer matrices for tissue engineering. Nat Biotech-
nol 17(6): 551–554. 
Son KK, Patel DH, Tkach D, Park A. 2000. Cationic liposome 
and plasmid DNA complexes formed in serum-free me-
dium under optimum transfection condition are negatively 
charged. Biochim Biophys Acta 1466(1–2):11–15. 
Stachelek SJ, Song C, Alferiev I, Defelice S, Cui X, Connolly 
JM, Bianco RW, Levy RJ. 2004. Localized gene delivery 
using antibody tethered adenovirus from polyurethane 
heart valve cusps and intra-aortic implants. Gene Ther 
11(1):15–24. 
Stuart MAC, Fleer GJ, Lyklema J, Norde W, Scheutjens JMHM. 
1991. Adsorption of ions, polyelectrolytes and proteins. 
Adv Colloid Interface Sci 34:477–535. 
Tseng WC, Haselton FR, Giorgio TD. 1997. Transfection by 
cationic liposomes using simultaneous single cell measure-
ments of plasmid delivery and transgene expression. J Biol 
Chem 272(41):25641–25647. 
Uchida E, Mizuguchi H, Ishii-Watabe A, Hayakawa T. 2002. 
Comparison of the efficiency and safety of non-viral vec-
tor-mediated gene transfer into a wide range of human 
cells. Biol Pharm Bull 25(7):891–897. 
Varga CM, Hong K, Lauffenburger DA. 2001. Quantitative 
analysis of synthetic gene delivery vector design proper-
ties. Mol Ther 4(5): 438–446. 
Wu RZ, Bailey SN, Sabatini DM. 2002. Cell-biological appli-
cations of transfected-cell microarrays. Trends Cell Biol 
12(10):485–488. 
Yoshikawa T, Uchimura E, Kishi M, Funeriu DP, Miyake M, 
Miyake J. 2004. Transfection microarray of human mesen-
chymal stem cells and on-chip siRNA gene knockdown. J 
Control Release 96(2):227–232. 
Zelphati O, Uyechi LS, Barron LG, Szoka FC Jr. 1998. Ef-
fect of serum components on the physico-chemical prop-
erties of cationic lipid/ oligonucleotide complexes and 
on their interactions with cells. Biochim Biophys Acta 
1390(2):119–133. 
Zhang X, Collins L, Fabre JW. 2001. A powerful cooperative 
interaction between a fusogenic peptide and lipofectamine 
for the enhancement of receptor-targeted, non-viral gene 
delivery via integrin receptors. J Gene Med 3(6):560–568. 
Ziauddin J, Sabatini DM. 2001. Microarrays of cells expressing 
defined cDNAs. Nature 411(6833):107–110. 
